Could vimseltinib be the next big thing in TGCT treatment? FDA says Yes!

The U.S. Food and Drug Administration (FDA) has granted priority review status to Deciphera Pharmaceuticals, Inc.'s New Drug Application (NDA) for vimseltinib, a drug developed ... Read More